US 9234000
Benzylamine derivatives as inhibitors of plasma kallikrein
granted A61KA61K38/00A61P
Quick answer
US patent 9234000 (Benzylamine derivatives as inhibitors of plasma kallikrein) held by KalVista Pharmaceuticals Limited expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KalVista Pharmaceuticals Limited
- Grant date
- Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61P, A61P1/04, A61P1/18